Memorial Sloan-Kettering finds value in CAD

Article

Radiologists at Memorial Sloan-Kettering Cancer Center are hoping that computer-aided diagnosis (CAD) will increase the number of cancers detected at an early stage. Radiologists are using CAD to second-read mammograms at the center's Breast

Radiologists at Memorial Sloan-Kettering Cancer Center are hoping that computer-aided diagnosis (CAD) will increase the number of cancers detected at an early stage.

Radiologists are using CAD to second-read mammograms at the center's Breast Examination Center of Harlem (BECH), an outreach program that provides free cancer screening and educational programs on cancer prevention and detection.

CAD technology, which uses a computer to scan mammograms for abnormalities, may improve early detection of breast cancer by almost 20%, according to one study(Freer TW, Ulissey MJ. Screening mammography with computer-aided detection: prospective study of 12,860 patients in a community breast center. Radiology 2001;220(3):781-786).

Memorial Sloan-Kettering acquired the same R2 Technology ImageChecker CAD system used in the Freer study and began using it in August for mammograms performed at BECH.

"We are encouraged by the growing body of research showing the potential value of CAD as a companion technology to mammography and we look forward to gaining experience with the system," said Dr. Michael A. Cohen, director of the Memorial Sloan-Kettering Guttman Diagnostic Center, where the mammograms are interpreted.

The technology may improve the proportion of cancers detected at an early stage and that in turn may encourage more women in the local community to obtain regular mammograms, Cohen said.

Every mammogram at BECH is first read in the conventional way by a staff radiologist, after which CAD analysis is conducted and reviewed. While the radiologist remains the decision-maker, the CAD system is believed to improve the radiologist's ability to detect breast cancer by pointing out an area or areas that may have been overlooked initially.

Each mammogram in the Freer study was first interpreted without the assistance of CAD. After CAD was used, the areas it indicated were immediately reevaluated. Data were recorded to measure the effect of CAD on the recall rate, positive predictive value for biopsy, cancer detection rate, and stage of malignancy at detection.

In a comparison of radiologists' performance with and without CAD, the authors observed the following:

?an increase in the recall rate from 6.5% to 7.7%;
?no change in the 38% positive predictive value for biopsy;
?a 19.5% increase in the number of cancers detected; and
?an increase from 73% to 78% in the proportion of early-stage (0 and I) malignancies detected.


The authors concluded that the use of CAD in interpreting screening mammograms can increase detection of early-stage malignancies without undue effect on the recall rate or positive predictive value for biopsy.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.